Search
for
Sort by
Research 751–780 of 1000+
- Pediatric Psychocutaneous Disorders
- Frontal Fibrosing Alopecia: Update and Review of Challenges and Successes
- Hirsutism, postpartum telogen effluvium, and male pattern alopecia
- Post-finasteride syndrome
- Cutaneous Blood Flow.
- The aetiopathogenesis of acne vulgaris - what's new?
- Clinical review 74: Dermatological manifestations of endocrine disorders.
- Sexual dysfunction in men taking systemic dermatologic medication: A systematic review
- Desideratum dermatologicum--cause and control of premenstrual acne flare
- Madarosis, milphosis, eyelash trichomegaly, and dermatochalasis
- Polycystic ovary syndrome: a dermatologic approach
- Use of H-1 Antihistamine in Dermatology: More than Itch and Urticaria Control: A Systematic Review
- The spectrum of nephrocutaneous diseases and associations
- Polycystic ovary syndrome: Challenges in adolescence
- Update on psychodermatological disorders
- Studying the efficacy of a new radical treatment for acne vulgaris using a surgical technique
- Rotterdam criteria–based diagnostic subtype is not a strong predictor of cutaneous phenotype in patients with polycystic ovary syndrome: A cross-sectional study
- Update on Frontal Fibrosing Alopecia
- LUPUS ERYTHEMATOSUS AND THE SKIN
- Performance exploration of multi-gene panels of alopecia areata susceptibility and drug-binding targets
- Hidradenitis Suppurativa/Acne Inversa/Dissecting Terminal Hair Folliculitis
- Cicatricial Alopecia
- Telogen Effluvium
- Sebum Production
- Homeodynamic Rejuvenation: an adaptive framework for resetting skin aging
- Alopecia and Its homoeopathic treatment
- A clinical investigation using reflectance confocal microscopy to evaluate the add-on efficacy of the Shumin treatment instrument combined with doxycycline for rosacea
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review
- Narrative Review of Skin and Pregnancy: Dermatologic Manifestations and Medication Management During Pregnancy
- TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen Planopilaris